Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-040581
Filing Date
2022-03-31
Accepted
2022-03-31 08:35:25
Documents
4
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2210822d1_6k.htm 6-K 11380
2 EXHIBIT 99.1 tm2210822d1_ex99-1.htm EX-99.1 128691
3 GRAPHIC tm2210822d1_ex99-1img0001.jpg GRAPHIC 3999
4 GRAPHIC tm2210822d1_ex99-1img01.jpg GRAPHIC 4093
  Complete submission text file 0001104659-22-040581.txt   152630
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 22789283
SIC: 2834 Pharmaceutical Preparations